Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FJADH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,792
Award facts
- Contract value 100% obligated
- $3,792.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $3,792.21. This competitive, non-set-aside award reflects a firm fixed-price delivery order to be completed by October 16, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the comprehensive vehicle for pharmaceutical and medical supply procurement supporting military healthcare operations globally.
As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, and medical supplies. This particular order for RINVOQ, a rheumatoid arthritis treatment, exemplifies the company's role in supporting military and veteran healthcare systems through the DLA's medical supply chain. The award demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements through competitive processes and represents one of numerous small-to-moderate value transactions executed under the larger SPE2DX prime vendor agreement.
Quick answers
Who was awarded contract SPE2DB26FJADH?
SPE2DB26FJADH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FJADH worth?
The government has obligated $3,792 on SPE2DB26FJADH.
Is contract SPE2DB26FJADH an order under another contract?
Yes. SPE2DB26FJADH is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB26FJADH competed?
The extent of competition for SPE2DB26FJADH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award